Lyudmila A. Bazhenova, MD

Lyudmila A. Bazhenova, MD

Lyudmila A. Bazhenova, MD, is a clinical professor of medicine at the University of California San Diego (UCSD); as well as a medical oncologist at the UCSD Moores Cancer Center

Articles by Lyudmila A. Bazhenova, MD

2 experts in this series

Lyudmila Bazhenova, MD, of UC San Diego Moores Cancer Center, asks Pasi A. Jänne, MD, PhD, of Dana-Farber Cancer Institute, about sunvozertinib in previously treated EGFR exon 20 insertion–mutated non–small cell lung cancer, where it is approved based on WU-KONG1B and carries a National Comprehensive Cancer Network Category 2A listing but is not yet available.

This Rapid Readout reviews clinical trials showing that sunvozertinib is an effective and manageable targeted therapy for non-small cell lung cancer patients with specific EGFR mutations, demonstrating strong antitumor activity after platinum-based chemotherapy and improved progression-free survival and response rates over standard chemotherapy as a first-line treatment.